Purpose. The protruding (P) 2 region of the norovirus capsid is thought to include hypervariable sites involved in receptor binding. This study examines the changes that occurred in the P2 region of GII.Pe_GII.4 norovirus in the course of its evolution from a precursor phase (2008)(2009), to an intermediate phase (2010) and finally to an epidemic phase (2012)(2013)(2014)(2015).
INTRODUCTION
The noroviruses, which are now considered the most common cause of outbreaks of nonbacterial gastroenteritis [1] , are single-stranded positive-sense RNA viruses comprising the genus Norovirus in the family Caliciviridae [2] . The human norovirus genome comprises three open reading frames (ORFs): ORF1 encodes the non-structural proteins, ORF2 encodes the major capsid protein (VP1) and ORF3 encodes the minor capsid protein (VP2) [2] .
Noroviruses have been classified into six genogroups of which three genogroups, I, II and IV (GI, GII and GIV), have been associated with human infections [2] . The genogroups can be further divided into genotypes [3] . The GII.4 genotype appears to be the most common in humans [4] and has been further divided into 'variants' [5] . Genotype classification can be based on either ORF1 or ORF2 nucleotide sequencing [6] .
The norovirus capsid comprises 90 protein dimers of VP1, each of which has two domains: the shell domain and the protruding (P) domain [2, 7] . The shell domain is involved in the formation of the icosahedral shell whereas the P domain forms arch-like protrusions [2] . The P domain has been divided into the P1 subdomain and the P2 subdomain [2] . The P1 subdomain forms the sides of the arch of capsomeres that make up the protruding zone and the P2 domain is at the top of the arch [2] . The P2 region is thought to be involved in receptor binding and immunogenicity [2] . More specifically, it has been postulated that five hypervariable sites in the P2 region, termed A, B, C, D and E, can act as neutralizing epitopes [8] . Furthermore, Lindesmith et al. [8] have suggested coevolution in these hypervariable sites may explain, to some degree, the success of human noroviruses such as the genotype GII. 4 , which appear to show an ability to escape host immune responses.
A previous study in this laboratory established that the epidemic norovirus strain GII.Pe_GII.4 underwent significant evolutionary change from the time of its emergence to its establishment as a major norovirus epidemic strain [9] . The current study examines the progressive amino acid (aa) changes that occurred in the P2 region of GII.Pe_GII.4 in the course of its evolution from the precursor stage in [2008] [2009] , intermediate stage in 2010, and then its manifestation as the epidemic strain in 2012. The subsequent development of the virus to 2015 was also examined. The findings are reviewed in relation to the progressive evolution of the virus and to the currently documented hypervariable sites [8] in the P2 region.
METHODS

Experimental plan
The experimental design is based on the study of Bruggink et al. [9] , which examined the emergence and evolution of the norovirus epidemic strain GII.Pe_GII.4_Sydney_2012 over the period 2008-2012. Bruggink et al. [9] identified three phases in the evolution of the epidemic form GII.Pe_GII.4_ Sydney_2012: a precursor phase (2008) (2009) , an intermediate phase (2010) and an epidemic phase (2012). The distinction between the three phases was made by examining changes in the yearly incidence of GII.Pe norovirus outbreaks over the period 2008-2012 as well as through an examination of how the yearly incidence related to nucleotide changes in GII.Pe itself and the ORF2 recombinant form. Thus it was noted that the virus underwent a significant genetic change in both ORF1 and ORF2 when the two periods 2008-2009 and 2012 were compared and this delineated the distinction between the precursor and epidemic phases. In the period 2008-2009, all the ORF2 sequences corresponded to the non-epidemic ORF2 variant GII.4_Osaka_2007, and in 2012, the GII.4 variant GII.4_Sydney_2012 was identified. However, nucleotide sequencing studies indicated outbreaks in 2010 had the features of the precursor phase in ORF1 but features of the epidemic phase in ORF2, thereby indicating 2010 represented an intermediate phase in the evolution of GII.Pe_GII.4_Syd-ney_2012. (GII.Pe_GII.4 was not found in 2011.) Subsequent testing in this laboratory and literature studies [10, 11] have shown that the epidemic phase has continued to 2015.
For the current study, selected GII.Pe_GII.4 specimens from each year (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) were chosen and analysed using RT-PCR and sequence analysis of the P2 region. The aa changes between phases were noted and their relationship with the five currently documented hypervariable sites (A, B, C, D and E) [8] examined. Protein modelling, based on the sequences obtained, was also carried out to determine the location of variable sites on a three-dimensional model of the P2 region protein.
Gastroenteritis outbreak definition
For the purposes of this study an outbreak of gastroenteritis was defined as an incident, apparently associated with a common event or location, in which four or more individuals had symptoms of gastroenteritis [12] .
The faecal specimens included in this study were those sent to the Victorian Infectious Diseases Reference Laboratory (VIDRL) for norovirus testing from outbreaks that occurred during 2008-2015. VIDRL is the main public health laboratory for viral identification in the state of Victoria, Australia. As such, it receives faecal material from gastroenteritis outbreaks reported to the Victorian Department of Health. Outbreak specimens are also occasionally sent by other institutions such as hospitals. Only outbreaks that occurred in Victoria were included in the study.
Faecal processing and RNA extraction
For the period 2008-2015, 9632 faecal specimens from 2324 gastroenteritis outbreaks were tested for norovirus. Faecal specimens were prepared as a 20 % (v/v) suspension [13] . RNA extraction was then carried out using the Corbett (now Qiagen) automated nucleic acid extraction procedure [14] .
Initial RT-PCRs, nucleotide sequencing and genotype definition An initial ORF1 RT-PCR that detects both GI and GII norovirus was carried out on all faecal specimens from gastroenteritis outbreaks received in the period 2008-2015 [15] . RT and first-round PCR were performed using the Qiagen One-
Step RT-PCR kit as follows. A 30 µl reaction mixture was prepared containing 16.8 µl kit nuclease-free water, 8 µl kit '5Â buffer', 1.6 µl kit dNTPs, 0.4 µl RNasin (Promega), 1.6 µl kit Taq mix, and 1.6 µl first-round primer mix with the primers each made to a concentration of 10 µM. Ten microlitres of the extracted RNA was added to this reaction mixture.
Second-round PCR was performed with the Qiagen Taq DNA polymerase 1000 units kit in a 38 µl reaction mixture containing 23.76 µl nuclease-free water (Promega), 8 µl kit '5xQ buffer', 4 µl kit '10Â buffer', 0.4 µl of 20 mM dNTPs (Promega), 0.24 µl kit Taq and 1.6 µl second-round primer mix with the primers each made to a concentration of 10 µM. Two microlitres of round 1 product was added to this reaction mixture.
ORF1 genotyping for all norovirus outbreaks involved sequencing analysis of one norovirus specimen, chosen without bias, from each outbreak where ORF1 RT-PCR identified a norovirus-positive specimen. The second-round PCR product of the ORF1 RT-PCR test procedure was purified and sequenced. A fragment of 440 nucleotides within the RNA polymerase region, corresponding to nucleotides 4484-4923 of GII.Pe_GII.4_Sydney_2012 virus (GenBank accession number JX459908), was utilized for genotype definition.
A GII ORF2 RT-PCR was then carried out on all noroviruspositive specimens which were identified as GII.Pe (ORF1) [9] . RT and first-round PCR and second-round PCR were carried out as above.
ORF2 nucleotide sequencing analysis was attempted on all ORF2 RT-PCR norovirus-positive specimens. A fragment of 195 nucleotides within the capsid gene, corresponding to nucleotides 5133-5327 of JX459908, was utilized for genotype definition.
Analysis of nucleotide sequences was carried out using MacVector software version 8.0 (Oxford Molecular Limited). Genotype identification was carried out using the norovirus typing tool of Kroneman et al. [16] .
P2 domain and P2 region definition
The GenBank record for GII.4_Sydney_2012 (GenBank accession number JX459908) gives the full capsid as being delineated by bases 5085-6707. Green [2] has indicated that the norovirus P2 domain corresponds to aa 279-405 of the capsid. This in turn corresponds to bases 5919-6299 of the whole genome of GII.Pe_GII.4_Sydney_2012 or bases 835-1215 of the capsid, and this was taken as the P2 domain in the current study. For the purposes of this study, the P2 region (which includes the P2 domain) was taken as aa 268-433 of the capsid, corresponding to bases 802-1299 of the capsid.
P2 region specimen selection
All specimens identified as GII.Pe in ORF1 and GII.4 in ORF2 over the period 2008 to 2015 were recorded and an unbiased representative selection for further studies on the P2 region RT-PCR was then made as follows. Firstly, the first specimen from an outbreak with both ORF1 (GII.Pe) and ORF2 (GII.4) sequencing data in a given calendar year was selected to be used in this study. Secondly, where there were more than six outbreaks in a calendar year, one specimen was selected from every second month after the first month in which the GII.Pe_GII.4 combination occurred that year. Thirdly, where there were fewer than six GII. Pe_GII.4 outbreaks in a calendar year, one specimen from each outbreak in that year was selected for study.
On this basis 33 specimens were chosen for P2 region analysis, although only 22 produced positive results using the P2 region RT-PCR. Of these 22 specimens, three were from the GII.Pe_GII 
P2 region RT-PCR and sequencing
The P2 region RT-PCR was carried out using a two-round RT-PCR with primers NV347a, NV347b, NV347c, NV348a, NV348b and NV348c (Table 1 ) based on those of Hohne et al. [17] . All primers were used in both rounds of the PCR. The first round of the PCR comprised an RT step carried out at 50 C for 30 min, followed by PCR with initial denaturation at 94 C for 5 min, then 30 cycles of denaturation at 94 C for 30 s, annealing at 50 C for 1 min and extension at 72 C for 3 min. An additional extension step was then carried out at 72 C for 10 min. The second-round PCR was performed as for the first round but without the RT step. RT and first-round PCR and second-round PCR were carried out as for the initial RT-PCR as above, except that primers were made to a concentration of 20 µM.
Sequencing studies were carried out as above using primers NV347a and NV347b. This generated a 498-bp fragment corresponding to bases 5886-6383 of JX459908, which in turn corresponded to 166 aa in frame (i.e. aa 268-433 of the capsid). This fragment, which is termed the P2 region for the current study, comprised the entire P2 domain (aa 279-405 of the capsid) as well as a portion of the connecting P1 domain at either end.
P2 region protein modelling
Norovirus amino acid sequence data derived from 2008 to 2015 specimens and a reference sequence, GII.4_Syd-ney_2012 (GenBank accession number JX459908), were uploaded to a SWISS-MODEL server workspace, www. swissmodel.expasy.org [18] . An initial 3D model representing the complete VP1 capsid protein was obtained using the GII.4_Sydney_2012 sequence data against a template structure derived from the norovirus capsid structure [19] , RCSB Protein Data Bank accession 1IHM. P2 region sequences from the reference strain JX459908 and representatives from 2008 to 2015 were modelled using the same process against RCSB Protein Data Bank accession 4OP7 [20] .
Upon completion of the 3D structural prediction, VP1 spatial data for the reference strain JX459908 was used to recreate a capsid structure in silico, using the biological assembly matrix metadata contained within the 1IHM template file. Capsid reconstruction was performed using the Visual Molecular Dynamics program (VMD) [21] as described previously for poliovirus [22] . The norovirus P2 region models in the current study were reconstructed into homodimers as indicated by the 4OP7 crystal structure.
Figs 1 and 3 were created by mapping the reference sequence (JX459908) shell and P1 structures derived from template 1IHM and the P2 region structures derived from the 4OP7 template into the same virtual space using VMD. Images were generated using the internal 'Tachyon' ray tracing renderer. Secondary structural elements were predicted using the STRIDE structure assignment algorithm [23] .
GenBank submission P2 region sequences (Fig. 2 ) from the precursor phase (May-08), intermediate phase (Jun-10a) and epidemic phase (Nov-15) were lodged in the GenBank database under accession numbers KX789174, KX789175 and KX789176, respectively.
RESULTS
Characteristics of the P2 region
The location of the 166-aa P2 region examined in the current study relative to a single norovirus capsid dimer is shown in Fig. 1 . It can be seen that it makes up the upper protruding region of the capsid dimer.
An alignment of the 166-aa sequences obtained over the period of the study is given in Fig. 2 and the locations of hypervariable sites A to E are indicated. It is notable that aa changes could take a variety of forms but most changes occurred in the earlier history of the virus and, once the epidemic phase began, relatively few changes occurred.
Amino acid changes
Distinct aa changes were noted during the evolution of the virus. For the purposes of this study, a distinct aa change was defined as a change in an aa which occurred in the majority of the sequences in a phase of the evolution of the virus. Twenty such changes were identified (Table 2) and it is also notable that 10 of the 20 aa changes involved one of the five hypervariable sites A to E.
The specific changes from phase to phase in the evolution of the virus can be seen in Fig. 2 (309 and 414), which were designated X and Y, were notable in that they only underwent change during the epidemic phase, rather than at the crossover from intermediate to epidemic phase. Neither corresponded to hypervariable sites A to E.
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Protein model
Diagrammatic views of the P2 region showing the location of the five hypervariable sites A to E proposed by Lindesmith et al. [8] and the two key sites recognised in the current study (X and Y) are shown in Fig. 3 . It can be seen that neither X nor Y is in the uppermost protruding 'crown' portion of the P2 region, but further down in the 'neck' portion.
DISCUSSION
Lindesmith et al. [8] , in a key study, identified five hypervariable sites, A to E, in the P2 region of the norovirus capsid which they suggested could evolve over time and drive antigenic change. The current study, which examined changes in the P2 region of the norovirus strain GII.Pe_GII.4 over an eight year period, presents a detailed evaluation of how the P2 region changed over time, and how these findings compared with those of related studies by other groups.
The evolution of the epidemic strain GII.Pe_GII.4_Syd-ney_2012 can be categorized into three distinct phases: precursor phase (2008-2009), intermediate phase (2010) and epidemic phase (2012 and onwards) [9] , and 20 distinct aa changes occurred in the course of these three phases. Of these 20 changes, 10 corresponded to the hypervariable sites proposed by Lindesmith et al. [8] . All five of the hypervariable sites (A-E) of Lindesmith et al. [8] were in some way involved in the evolution of the virus, with hypervariable sites A and E being the most important. Most of the changes occurred early in the evolution of the virus and by the epidemic phase the virus had largely, but not completely, stabilized.
There is now evidence that the norovirus P2 region is involved in a number of roles including antibody and receptor binding [2, 24] . Carbohydrates, including those found on various histo-blood group antigens (HBGAs), are known to interact with the norovirus capsid [2] . The precise details of how noroviruses bind to HBGAs appear to be complex, and variations in HBGA binding have been noted between norovirus genogroups and within a single norovirus genotype [25] . Clearly any novel information could be useful in understanding these interactions.
A number of studies have attempted to assign either an antibody-binding or HBGA-binding role to specific sites in the P region. For example Debbink et al. [24] and de Rougemont et al. [26] have presented evidence that epitope D is an HBGA-binding site and Debbink et al. [24] presented evidence that epitope A is an antibody-binding site. In this It is notable that these two sites correspond to hypervariable sites A and E, and aa changes at both these sites were found in the current study. Kulkarni et al. [29] sequenced the ORF2 region of GII.4 noroviruses identified in India during the period 2005-2013 and noted that the GII.4_Sydney_2012 variant showed changes at sites 294 and 368 compared to the previous GII.4 variant, GII.4_NewOrleans_2009. Both these sites correspond to hypervariable site A and aa transitions at both these sites were found in the current study.
In the current study, two sites unrelated to those of Lindesmith et al. [8] were particularly significant. The sites, designated X and Y, only showed changes during the epidemic phase and therefore appeared to be somehow linked to maintenance of the ongoing virulence of the virus. The change at site Y involved a change from histidine to proline and this appears to be a major change in that it involves a change from a positively charged aa to a polar, uncharged aa, with a rigid ring structure that reduces structural flexibility [30] . The change at site X involved a change from asparagine to serine, which appears to be only a minor change as both amino acids are polar and uncharged [30] .
Modelling studies indicated that neither the X nor Y sites were in the uppermost protruding 'crown' portion of the P region but further down in the 'neck' portion. The positioning of the two sites, and the aa change at site Y, suggest they played a role by enhancing the structural integrity of the capsid, which in turn may have facilitated the longer term viability of the virus.
It is noteworthy that Qiao et al. [31] examined changes in GII.4 sequences in the 12 year period 2004-2015 in China and changes in the P domain of two GII.4 variant forms, Den Haag_2006b and Sydney_2012 (the variant form examined in the current study). In particular Qiao et al. [31] reported aa changes in their two GII.4 variant forms at the sites termed X and Y in the current study,
Changes at the site in the study of Qiao et al. [31] corresponding to site X in the current study (at position 309) were only identified in Sydney_2012 (and not in Den Haag_2006b). In the current study the aa at site X changed from asparagine to serine and the same change was noted by Qiao et al. [31] . Qiao et al. [31] described the change in structure induced by this aa change as 'subtle' but with the potential to influence the carbohydrate binding of the capsid.
Amino acid changes at the site in the study of Qiao et al. [31] corresponding to the Y site in the current study (at position 414) were only identified in Den Haag_2006b (and not in Sydney_2012). In the current study the aa at Y changed from histidine to proline and the same change was noted by Qiao et al. [31] . Qiao et al. [31] also discussed this specific change and noted it had the effect of reducing the space in the vicinity of epitope E and this, in turn, had the potential to influence carbohydrate interactions at the site.
In summary, it is striking that Qiao et al. [31] noted identical changes in GII.4 strains at sites X and Y to those found in the current study and interpreted these as having the potential to influence carbohydrate binding. The findings of the current study suggest an alternative, though not necessarily contradictory, interpretation of the changes at sites X and Y. Modelling studies indicated that neither the X nor Y site was in the uppermost protruding 'crown' portion of the P region, but further down in the 'neck' portion. The positioning of the two sites, and the aa change at site Y, suggest they enhanced the structural integrity of the capsid, which in turn may have facilitated the longer term viability of the virus.
The current study helps establish the validity of the proposal of Lindesmith et al. [8] in relation to key sites in the norovirus P2 region. It also provides confirmatory evidence for other studies on such sites in the GII.4 genotype. However, it also identifies a large number of additional hypervariable sites. In particular, the current study identified two sites, X and Y, as being of particular interest, as the aa changes here only occurred later in the evolution of the virus and presumably contributed to its ongoing survivability.
